Angkor Resources Announces Closing of Financing $3,500,000

Angkor Resources closed a non-brokered private placement with Sorbie Bornholm LP for gross proceeds of $3.5 million, structured as 14 million shares at $0.25 and warrants, with proceeds and securities released in 24 monthly tranches. Sorbie’s subscription proceeds are backed by UK government bonds valued at not less than $3.5 million; Angkor’s proceeds at each settlement vary with VWAP relative to a $0.3144 benchmark. Angkor also paid a $210,000 corporate finance fee in shares and warrants and will pay a $175,000 finder’s fee in monthly cash tranches, plus 700,000 finder warrants.

Analysis

This is not equivalent to $3.5M of immediately deployable cash. Proceeds are held in UK government bonds and released over 24 months, while the monthly cash received varies with ANK’s VWAP relative to $0.3144. Below that level, ANK receives less than the scheduled release even though the corresponding shares are released; above it, the company can receive more, with no stated cap on the extra proceeds. The central risk is therefore a feedback loop: weak trading can reduce near-term liquidity just when financing needs may be greatest. Verify whether any shortfall is deferred, forfeited, or otherwise recoverable—the release does not make that clear.

The other side of the structure is a sustained supply overhang: monthly share releases, additional warrant issuance, and fee securities. The 9.99% blocker limits Sorbie’s ownership at a point in time, not necessarily its ability to sell released shares and later exercise warrants. The $210,000 finance fee plus $175,000 finder cash fee equals 11% of gross proceeds before considering security dilution. Escrow and bond collateral temper immediate counterparty risk, but do not eliminate the execution, liquidity, or dilution costs.

Near term, the headline may be mildly supportive because the financing has closed, but the cash is staged rather than fully available. Over 1–3 months, track each settlement, VWAP versus $0.3144, and TSXV acceptance. Over 6–18 months, deployment progress and the realized dilution/supply path matter more than headline proceeds. The contrarian point: collateralized proceeds can look like funding certainty, but the value to ANK is market-price-dependent. No valuation or liquidity data support a directional trade today.

Key Decisions for Investors

• Do not treat the announcement as an immediate $3.5M cash infusion in ANK models. Confirm monthly settlement mechanics, including the treatment of any below-benchmark shortfall, and monitor cash actually released.
• Watch ANK’s VWAP relative to $0.3144 at each monthly settlement. Persistent trading below that level would weaken the funding thesis; sustained trading above it would improve proceeds economics, subject to company disclosure.
• Treat released shares and staged warrants as an overhang rather than assuming the 9.99% blocker prevents eventual dilution or selling. Reassess after escrow releases and warrant issuance are reported.
• No standalone long or short is warranted from this release alone. Revisit only with verified TSXV acceptance, cash-use details, settlement disclosures, and evidence that funded projects can create value in excess of the financing and dilution cost.